Clinical Trial Update: Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx [Phase 2]

View source ↗

Summary

A Phase II/III clinical trial evaluating interleukin-2 for preservation of CD4 T-lymphocytes after interruption of antiretroviral therapy in HIV-infected patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Aldesleukin (Interleukin-2) (Interleukin-2)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2010-10-05